Ondansetron prevents refractory and severe methotrexate-induced nausea in rheumatoid arthritis.
Blanco
R
R
González-Gay
M A
MA
García-Porrúa
C
C
Ibañez
D
D
García-Pais
M J
MJ
Sánchez-Andrade
A
A
Vázquez-Caruncho
M
M
D000932:Antiemetics / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D017294:Ondansetron / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome
D000932:Antiemetics; D018501:Antirheumatic Agents; D017294:Ondansetron; D008727:Methotrexate